Spruce Biosciences, Inc. (SPRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.3200 |
| Open | 1.3600 |
| Bid | 1.2500 x 800 |
| Ask | 1.4900 x 1000 |
| Day's range | 1.3000 - 1.4000 |
| 52-week range | 1.2500 - 15.0800 |
| Volume | |
| Avg. volume | 123,311 |
| Market cap | 31.95M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
5 Beaten-Down Biotech Bets to Bounce Back in 2022
Biotech stocks from the Medical sector, including APTO, CELU, CNSP, CYAD and SPRB, might be witnessing a turnaround in 2022 to emerge as solid investment options.
- Zacks
Spruce Biosciences, Inc. (SPRB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Spruce Biosciences, Inc. (SPRB) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
- Zacks
Why Earnings Season Could Be Great for Spruce Biosciences (SPRB)
Spruce Biosciences is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
© 2022 Yahoo. All rights reserved.
